Thomas Steyer's hedge fund firm Farallon Capital has just now filed a 13G on shares of Horizon Pharma (HZNP). This is a brand new position for the hedge fund as they did not report ownership back in the second quarter.
Farallon has disclosed a 5.4% ownership stake in the company with 1,883,071 shares. The SEC filing was required due to portfolio activity on September 7th.
Per Google Finance, Horizon Pharma is "a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases."
Monday, September 17, 2012
Farallon Capital Discloses New Stake in Horizon Pharma
blog comments powered by Disqus
